You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,528,104


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,528,104
Title:Peptides that bind to the erythropoietin receptor
Abstract: The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.
Inventor(s): Holmes; Christopher P. (Saratoga, CA), Yin; Qun (Palo Alto, CA), Lalonde; Guy (Woodside, CA), Schatz; Peter J. (Cupertino, CA), Tumelty; David (Sunnyvale, CA), Palani; Balu (Cupertino, CA), Zemede; Genet (Santa Clara, CA)
Assignee: Affymax, Inc. (Palo Alto, CA)
Application Number:10/555,868
Patent Claim Types:
see list of patent claims
Compound; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,528,104: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 7,528,104, providing a thorough analysis of its scope, claims, and the broader patent landscape.

Understanding Patent Scope and Claims

Before diving into the specifics of Patent 7,528,104, it is essential to understand what patent scope and claims entail.

Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is often measured using metrics such as independent claim length and independent claim count, which can indicate the complexity and breadth of the invention[3].

Patent Claims

Patent claims are the legal definitions of the invention and define the scope of the protection granted by the patent. They are typically divided into independent and dependent claims, with independent claims standing alone and dependent claims referring back to an independent claim[3].

Patent 7,528,104: Overview

To analyze Patent 7,528,104, we need to identify its key components:

Title and Abstract

The title and abstract provide a brief overview of the invention. While the specific details of Patent 7,528,104 are not provided here, these sections are critical in understanding the general nature of the invention.

Background of the Invention

This section explains the context and prior art related to the invention. It helps in understanding why the invention was necessary and how it improves upon existing technologies.

Summary of the Invention

This section provides a concise description of the invention, including its main features and how it operates.

Detailed Analysis of Claims

Independent Claims

Independent claims define the invention in its broadest terms. They are crucial because they set the boundaries of what is protected by the patent. For example, an independent claim might describe the overall system or method of the invention without referencing other claims.

Dependent Claims

Dependent claims narrow down the invention by adding specific details or limitations to the independent claims. These claims are often used to protect specific embodiments or variations of the invention.

Analyzing the Scope of Patent 7,528,104

To analyze the scope, we would typically look at the following:

Claim Length and Count

Research has shown that narrower claims, as measured by claim length and count, are associated with a higher probability of grant and a shorter examination process[3].

Forward Citations and Patent Maintenance Payments

Forward citations (how often the patent is cited by later patents) and patent maintenance payments can also indicate the scope and importance of the patent. Patents with more forward citations and higher maintenance payments generally have broader scope and greater impact[3].

Patent Landscape and Trends

Understanding the broader patent landscape is essential for contextualizing Patent 7,528,104.

Technology Area Classification

Patents are classified into various technology areas, such as electrical engineering, mechanical engineering, and chemistry. The classification helps in identifying trends and hotspots in innovation. For instance, electrical engineering patents, including those related to information and communication technologies (ICT), have seen significant growth between 2000 and 2018[4].

Global and Domestic Trends

The USPTO awards a substantial number of patents each year, with a significant portion going to foreign inventors. In 2018, the USPTO awarded 309,000 utility patents, nearly equally divided between foreign and domestic inventors[4].

Industry and Academic Sector Involvement

Businesses receive the majority of patents, but the academic sector and government also play significant roles. Understanding the distribution of patents among different sectors can provide insights into where innovation is happening and who the key players are[4].

Tools and Resources for Patent Analysis

Several tools and resources are available for conducting a thorough patent analysis:

Patent Public Search

The USPTO's Patent Public Search tool provides enhanced access to prior art and is a powerful resource for searching existing patents and published patent applications[1].

Global Dossier

The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from participating IP Offices, enabling users to visualize search results for the same invention on a single page[1].

Legal and Policy Considerations

The legal and policy framework surrounding patents is complex and evolving.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and accessibility. Such a court could significantly impact how patent disputes are resolved[2].

Patent Quality and Scope

Debates over patent quality often focus on the breadth and clarity of patent claims. Narrower claims are generally associated with higher patent quality and reduced litigation costs[3].

Key Takeaways

  • Patent Scope and Claims: Understanding the scope and claims of a patent is crucial for determining the breadth of protection.
  • Technology Area Classification: Patents are classified into specific technology areas, which helps in identifying trends and innovation hotspots.
  • Global and Domestic Trends: The USPTO awards a significant number of patents to both foreign and domestic inventors.
  • Tools and Resources: Utilize tools like Patent Public Search, Global Dossier, and CCD for comprehensive patent analysis.
  • Legal and Policy Considerations: The legal framework, including potential small claims patent courts, can impact patent litigation and quality.

FAQs

What is the significance of independent claims in a patent?

Independent claims define the invention in its broadest terms and set the boundaries of what is protected by the patent.

How can the scope of a patent be measured?

The scope of a patent can be measured using metrics such as independent claim length and independent claim count, as well as by analyzing forward citations and patent maintenance payments.

What is the Global Dossier service, and how does it help in patent analysis?

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, allowing users to view the patent family and related data in a single portal.

Why is the classification of patents into technology areas important?

Classification helps in identifying trends and innovation hotspots, and it allows for the aggregation of data to analyze trends in patenting focus over time.

What is the role of the USPTO in patent analysis and protection?

The USPTO is responsible for awarding patents, maintaining databases, and providing tools such as Patent Public Search and Global Dossier to facilitate patent analysis and protection.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. NCSES - Invention: U.S. and Comparative Global Trends: https://ncses.nsf.gov/pubs/nsb20204/invention-u-s-and-comparative-global-trends

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,528,104

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Takeda Pharms Usa OMONTYS peginesatide acetate SOLUTION;INTRAVENOUS, SUBCUTANEOUS 202799-007 Mar 27, 2012 DISCN No No 7,528,104 ⤷  Subscribe Y Y ⤷  Subscribe
Takeda Pharms Usa OMONTYS peginesatide acetate SOLUTION;INTRAVENOUS, SUBCUTANEOUS 202799-008 Mar 27, 2012 DISCN No No 7,528,104 ⤷  Subscribe Y Y ⤷  Subscribe
Takeda Pharms Usa OMONTYS PRESERVATIVE FREE peginesatide acetate SOLUTION;INTRAVENOUS, SUBCUTANEOUS 202799-001 Mar 27, 2012 DISCN No No 7,528,104 ⤷  Subscribe Y Y ⤷  Subscribe
Takeda Pharms Usa OMONTYS PRESERVATIVE FREE peginesatide acetate SOLUTION;INTRAVENOUS, SUBCUTANEOUS 202799-002 Mar 27, 2012 DISCN No No 7,528,104 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,528,104

PCT Information
PCT FiledMay 12, 2004PCT Application Number:PCT/US2004/014886
PCT Publication Date:November 25, 2004PCT Publication Number: WO2004/101611

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.